Programme
28th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE
The full programme can be downloaded in pdf by clicking here
Friday, April 8th, 2022
Posters are displayed in “Lille Sal”. Posters should be in place before 9.00 and removed after the last poster session of the day. You should be present at your poster during all poster sessions of the day. Your poster should be placed on the board with your number on.
Session IV. CASRIOVASCULAR DISEASE |
|
No 27 |
Female patients with familial hypercholesterolemia have higher cholesterol burden at 19 and 30 years of age: data from 12-years follow-up. |
No 28 |
Elevated remnant cholesterol appropriately reclassifies individuals who develop myocardial infarction |
No 30 |
The Lp(a) equivalent to FH in ASCVD risk: CGPS |
No 33 |
Familial Hypercholesterolemia prevalence among ethnicities – systematic review and meta-analysis |
15.15 – 16.00: |
YIA Poster Walk . Selected abstracts (3 min presentation + 2 min discussion) |
No 29 |
Viral transgene delivery to endothelial cells in mouse models
|
No 31 |
Unraveling macrophage heterogeneity in human atherosclerosis |
No 34 |
A Trojan horse in contrast-enhanced MRI? Superparamagnetic iron oxide nanoparticles enhance apoptosis in human and murine atherosclerosis |
No 38 |
Severe a1-antitrypsin deficiency associated with increased risk of heart failure in two large populations |
No 41 |
ApoB and non-HDL cholesterol versus LDL cholesterol for ischemic stroke risk |
No 42 |
ApoM is associated with prevalent cardiovascular disease in patients with chronic kidney disease |
No 48 |
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomized ASSAIL-MI trial |